Fresenius SE & Co. KGaA Stock

Price

Target price

/ Tradegate WKN: 578560 / Symbol: FSNUF / Name: Fresenius / Stock / Healthcare Providers & Services / Large Cap /

Please give a prediction to see the opinions of the community

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Your prediction

Fresenius SE & Co. KGaA Stock

Fresenius SE & Co. KGaA shows a slight decrease today, losing -€0.270 (-0.580%) compared to yesterday.

So far the community has only identified positive things for Fresenius SE & Co. KGaA stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Fresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.

Feedback

Pros and Cons of Fresenius SE & Co. KGaA in the next few years

Pros

G***** c******* t* c**********

C******** o* t** e**********

W********* I********* f** t** n*** y****

Cons

B****

M***** P*******

S********** s********

Tell us your opinion to access the 'Wisdom of the Crowds'

Your Opinion

Legal notice

Performance of Fresenius SE & Co. KGaA vs. its peers

Security	Change(%)	1w	1m	1y	YTD	3y	5y
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA ADR
Fresenius Medical Care AG & Co KGaA ST
Quest Diagnostics Inc.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.

Last updated at 2024-08-01

Analyzing the financials of Fresenius (FSNUF) offers insights into a multifaceted healthcare provider navigating a complex landscape. The company exhibits a blend of strengths and challenges that reveal important considerations for investors and stakeholders alike. The financial statements reflect a robust operational presence, although there are areas requiring caution. Overall, a nuanced perspective is essential when evaluating Fresenius' financial stability and growth potential.

Pros of Fresenius Financials:

Strong Revenue Generation: With total revenue reported at approximately €22.46 billion for the trailing twelve months, Fresenius demonstrates robust capacity to generate income. This solid revenue stream, coupled with a consistent gross profit of around €10.73 billion, showcases the company’s ability to maintain a profitable operation within the healthcare sector.

Feedback